INGREZZA Reviews (VALBENAZINE TOSYLATE)

Average Rating: 1.7 (4 Ratings)

Filter Results

Compare INGREZZA with similar:

 Type: Rx Drug

  

INGREZZA  (VALBENAZINE TOSYLATE):  Valbenazine is used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).   FDA Approval Date: 2017-04-11 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR INGREZZACOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  TD Brain fog. Feeling of not being aware of the moment. Nausea enhanced. F 63 7 days
40mg 1X day
3/1/2022
 1  Movement F 63 1 years
40 1X day
10/23/2021
 4  Tardive Dyskinesia After taking it for a few days my tardive stopped very fast, but after more than a year and six months I started having Parkinson's symptoms and if you take paxil with Ingrezza I was told you should only take the 40 mg of Ingrezza but I was taking 80 and they don't know if I switch to 40 mg if the Parkinson's symptoms will go away because I was on 80mg for so long.I am seeing a neurologist that is very good and I will try reducing the mg to 40 .they are not sure if I have the start of Parkinson's or if it is caused by the paxil and ingrezza , I'm hoping it's the meds. F 59 2 years
80 mg 1X day
3/8/2021
 1  Tardive dyskinesia Akathisia, worsening TD symptoms. This seems like the drug industry's attempt to capitalize on an epidemic they created. How awful to make people who are already suffering suffer more. Terrible drug! F 50 3 weeks
11/29/2019
  

INGREZZA  (VALBENAZINE TOSYLATE):  Valbenazine is used to treat involuntary movements of the face, tongue, or other body parts (tardive dyskinesia). This medication is thought to work by decreasing the amount of certain natural substances in the brain that affect how your nerves and muscles work (monoamines such as dopamine, serotonin, and norepinephrine).   FDA Approval Date: 2017-04-11 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP